The University of Southampton
University of Southampton Institutional Repository

Nitrite and myocardial ischaemia reperfusion injury. Where are we now?

Nitrite and myocardial ischaemia reperfusion injury. Where are we now?
Nitrite and myocardial ischaemia reperfusion injury. Where are we now?

Cardiovascular disease remains the leading cause of death worldwide despite major advances in technology and treatment, with coronary heart disease (CHD) being a key contributor. Following an acute myocardial infarction (AMI), it is imperative that blood flow is rapidly restored to the ischaemic myocardium. However, this restoration is associated with an increased risk of additional complications and further cardiomyocyte death, termed myocardial ischaemia reperfusion injury (IRI). Endogenously produced nitric oxide (NO) plays an important role in protecting the myocardium from IRI. It is well established that NO mediates many of its downstream functions through the 'canonical' NO-sGC-cGMP pathway, which is vital for cardiovascular homeostasis; however, this pathway can become impaired in the face of inadequate delivery of necessary substrates, in particular L-arginine, oxygen and reducing equivalents. Recently, it has been shown that during conditions of ischaemia an alternative pathway for NO generation exists, which has become known as the 'nitrate-nitrite-NO pathway'. This pathway has been reported to improve endothelial dysfunction, protect against myocardial IRI and attenuate infarct size in various experimental models. Furthermore, emerging evidence suggests that nitrite itself provides multi-faceted protection, in an NO-independent fashion, against a myriad of pathophysiologies attributed to IRI. In this review, we explore the existing pre-clinical and clinical evidence for the role of nitrate and nitrite in cardioprotection and discuss the lessons learnt from the clinical trials for nitrite as a perconditioning agent. We also discuss the potential future for nitrite as a pre-conditioning intervention in man.

Cardiotonic Agents/pharmacology, Clinical Trials as Topic, Humans, Myocardial Reperfusion Injury/prevention & control, Nitrites/pharmacology
0163-7258
107819
Griffiths, Kayleigh
0a807d8e-54aa-4c82-b5e7-3656cde837fd
Lee, Jordan J.
3f24f9f8-1acb-4cf7-aa10-783dfeaecab4
Frenneaux, Michael P.
82824b6d-51f1-4b31-9f7a-5b4746d59833
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Madhani, Melanie
63a48cca-67b7-41ae-bc79-0f4a166f0750
Griffiths, Kayleigh
0a807d8e-54aa-4c82-b5e7-3656cde837fd
Lee, Jordan J.
3f24f9f8-1acb-4cf7-aa10-783dfeaecab4
Frenneaux, Michael P.
82824b6d-51f1-4b31-9f7a-5b4746d59833
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Madhani, Melanie
63a48cca-67b7-41ae-bc79-0f4a166f0750

Griffiths, Kayleigh, Lee, Jordan J., Frenneaux, Michael P., Feelisch, Martin and Madhani, Melanie (2021) Nitrite and myocardial ischaemia reperfusion injury. Where are we now? Pharmacology & Therapeutics, 223, 107819. (doi:10.1016/j.pharmthera.2021.107819).

Record type: Review

Abstract

Cardiovascular disease remains the leading cause of death worldwide despite major advances in technology and treatment, with coronary heart disease (CHD) being a key contributor. Following an acute myocardial infarction (AMI), it is imperative that blood flow is rapidly restored to the ischaemic myocardium. However, this restoration is associated with an increased risk of additional complications and further cardiomyocyte death, termed myocardial ischaemia reperfusion injury (IRI). Endogenously produced nitric oxide (NO) plays an important role in protecting the myocardium from IRI. It is well established that NO mediates many of its downstream functions through the 'canonical' NO-sGC-cGMP pathway, which is vital for cardiovascular homeostasis; however, this pathway can become impaired in the face of inadequate delivery of necessary substrates, in particular L-arginine, oxygen and reducing equivalents. Recently, it has been shown that during conditions of ischaemia an alternative pathway for NO generation exists, which has become known as the 'nitrate-nitrite-NO pathway'. This pathway has been reported to improve endothelial dysfunction, protect against myocardial IRI and attenuate infarct size in various experimental models. Furthermore, emerging evidence suggests that nitrite itself provides multi-faceted protection, in an NO-independent fashion, against a myriad of pathophysiologies attributed to IRI. In this review, we explore the existing pre-clinical and clinical evidence for the role of nitrate and nitrite in cardioprotection and discuss the lessons learnt from the clinical trials for nitrite as a perconditioning agent. We also discuss the potential future for nitrite as a pre-conditioning intervention in man.

This record has no associated files available for download.

More information

e-pub ahead of print date: 15 February 2021
Published date: July 2021
Keywords: Cardiotonic Agents/pharmacology, Clinical Trials as Topic, Humans, Myocardial Reperfusion Injury/prevention & control, Nitrites/pharmacology

Identifiers

Local EPrints ID: 456297
URI: http://eprints.soton.ac.uk/id/eprint/456297
ISSN: 0163-7258
PURE UUID: e15878a5-0318-4d82-83f1-0cc2ef354fe3
ORCID for Martin Feelisch: ORCID iD orcid.org/0000-0003-2320-1158

Catalogue record

Date deposited: 27 Apr 2022 02:06
Last modified: 17 Mar 2024 03:27

Export record

Altmetrics

Contributors

Author: Kayleigh Griffiths
Author: Jordan J. Lee
Author: Michael P. Frenneaux
Author: Martin Feelisch ORCID iD
Author: Melanie Madhani

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×